Tak 242
TAK-242 is a small molecule inhibitor that targets the Toll-like receptor 4 (TLR4) signaling pathway. It acts as an antagonist of TLR4, which plays a crucial role in the innate immune response. The core function of TAK-242 is to inhibit TLR4-mediated signaling, which can be used in research applications.
Lab products found in correlation
5 protocols using tak 242
Inhibition of Inflammatory Pathways
Inhibition of Mycobacterial-Induced Inflammation
Inhibitor Compounds for Inflammation Studies
Intrathecal Infusion of Pharmacological Agents in Rats
In all groups, we used a microsyringe to intrathecally infuse 10 μl of normal saline, 20 μg/10 μl of CXCL12-neutralizing antibody (R&D Systems, USA), 10 μg/10 μl of control IgG antibody (R&D Systems, USA), 10 μg/10 μl of CXCR4-specific antagonist (AMD3100, EMD Millipore, USA) or 30 μg/10 μl of TAK-242 (EMD Millipore, USA). All drug doses were based on the results of preliminary experiments. Intrathecal infusions were administered for 5 consecutive days before surgery, and neurological signs were assessed after each injection. Only the rats with normal motor and sensory function were included in the follow-up experiments.
TLR4 Antagonist-Mediated Neuroprotection
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!